These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12866033)

  • 21. RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.
    Porkka KP; Tammela TL; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2004 Jan; 39(1):1-10. PubMed ID: 14603436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of ERalpha and ERbeta in prostate cancer.
    Linja MJ; Savinainen KJ; Tammela TL; Isola JJ; Visakorpi T
    Prostate; 2003 May; 55(3):180-6. PubMed ID: 12692783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
    Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
    Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.
    Lin VK; Wang D; Lee IL; Vasquez D; Fagelson JE; McConnell JD
    Prostate; 2000 Aug; 44(3):193-203. PubMed ID: 10906735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma.
    Nojima D; Li LC; Dharia A; Perinchery G; Ribeiro-Filho L; Yen TS; Dahiya R
    Cancer; 2001 Oct; 92(8):2076-83. PubMed ID: 11596023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens.
    Granchi S; Brocchi S; Bonaccorsi L; Baldi E; Vinci MC; Forti G; Serio M; Maggi M
    Prostate; 2001 Dec; 49(4):267-77. PubMed ID: 11746273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time quantitative reverse transcriptase-polymerase chain reaction for luteinizing hormone-releasing hormone receptor gene mRNA expression in human prostate cancer.
    Straub B; Müller M; Krause H; Schrader M; Miller K
    Urology; 2003 Jul; 62(1):172-6. PubMed ID: 12837461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.
    Wu GJ; Varma VA; Wu MW; Wang SW; Qu P; Yang H; Petros JA; Lim SD; Amin MB
    Prostate; 2001 Sep; 48(4):305-15. PubMed ID: 11536311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
    Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
    Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
    Zhao H; Ramos CF; Brooks JD; Peehl DM
    J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
    Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
    Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
    Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
    Bouras T; Frauman AG
    J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of androgen receptor coregulators in prostate cancer.
    Linja MJ; Porkka KP; Kang Z; Savinainen KJ; Jänne OA; Tammela TL; Vessella RL; Palvimo JJ; Visakorpi T
    Clin Cancer Res; 2004 Feb; 10(3):1032-40. PubMed ID: 14871982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K; Uemura H; Ishiguro H; Kubota Y
    Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
    Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA
    Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat.
    Ouyang XS; Wang X; Lee DT; Tsao SW; Wong YC
    Carcinogenesis; 2001 Jun; 22(6):965-73. PubMed ID: 11375906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
    Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
    Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.